text.skipToContent text.skipToNavigation
Need help? Please contact us
Pharma & Biotech

Fresh Human Naive T Cells (Cord Blood)

Catalog #: 3C-202
Human CD4+/CD45RA+ Naive T cells, isolated from cord blood using negative immunomagnetic selection, ≥ 5 million cells, fresh

Product Overview

A fresh cord from a single donor is used to positively select Naïve T cells using a two step isolation process. CD4+ T Cells are first negatively selected from MNC using an indirect immunomagnetic CD4+ labeling system. CD45RO microbeads are then used to deplete the CD45RO+ population, leaving a highly enriched CD4+ CD45RA+ Naïve T Cell population. Cells are formulated in Lonza Fresh Media and shipped in a transport tube. Cell purity is determined using a FACS assay. Count and viability is determined using AO/PI.


  • Antigen presenting cell (APC) signal transduction and antigen presentation

Content & Storage


1 vial fresh cells containing ≥ 5M cells

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Need a Quote or Any Support?

Request a local representative to get back to you with additional information or pricing.

Immunotherapy and Hematopoietic Knowledge Center

The Immunotherapy and Hematopoietic Knowledge Center is dedicated to sharing interesting articles and resources related to immuno and hematopoietic research.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.